Recently Featured
Robert F.
Masella
1345 Avenue of the Americas
New York, NY 10105-0302
Education
J.D., University of Pennsylvania Law School, magna cum laude
M.B.A., Wharton School, University of Pennsylvania, with distinction
B.A., College of William & Mary, magna cum laude
General Course, London School of Economics
Bar Admissions
New York
Rob Masella is a partner in the firm’s Mergers & Acquisitions Group. He has decades of experience advising public and private companies, corporate boards, private equity funds and financial institutions on complex domestic and cross-border M&A transactions across sectors. His practice includes advising on public and private M&A, dual-track M&A/IPO processes, joint ventures, option agreements, licensing and collaboration agreements and spin-offs. His broad experience spans many industries with a particular emphasis on life sciences. Rob also advises boards of directors on corporate governance, shareholder activism, fiduciary duties and conflict-of-interest matters.
Rob’s experience includes advising:
- Color Wow in its sale to L’Oréal
- SpringWorksin its merger with Merck KGaA
- Ally Bridge in numerous investments
- 2seventy bio in its merger with BMS
- Teleflexin its acquisition of Biotronik's cardiovascular business
- Ironshore Therapeutics in its sale to Collegium
- Proteologixin its sale to Johnson & Johnson
- Thomson Reuters in multiple transactions, including its acquisitionsof Materia, Noetica,Additive AI, REDI Technologies and Capital Confirmation and the sale of Gardiner-Caldwell, Physicians World, Physicians’ Desk Reference and Scientific Connexions
- Pathos AI in its acquisition of Rain Oncology
- AVROBIO in its merger with Tectonic
- Acinoin its acquisition of M8 Pharmaceuticals
- VersanisBio in its sale to Eli Lilly
- Checkmate Pharmaceuticals in its merger with Regeneron
- AvroBioin its gene therapy sale to Novartis
- Intapp in its acquisitionsof Paragon Data Labs, OnePlace, DealCloudandRepstorLimitedand in its IPO
- TCR2 in its merger with Adaptimmune
- Henry Schein in its partnership with Rimidi
- Caris Life Sciences in over $1 billion of growth equity financing
- AcelRx in its acquisition of Lowell Therapeutics
- OpenAI Foundation in numerous life science grants
- MeiraGTx Holdings plc in its acquisition of Emrys Bio
- Alnylam in various corporate governance matters
- AcelRx in various corporate matters
- Ultragenyx in its investment in Arcturus Therapeutics
- Sonic Corp. in its sale to Inspire Brands
- Knauf in its acquisition of USG Corporation for $7 billion
- Knauf in its withhold campaign at USG Corporation
- Retromer Pharma in multiple equity financings
- Inspirna in various collaborations
- MedeAnalytics in its acquisition of assets from The Advisory Board Company
- MedeAnalytics, a portfolio company of Bain Capital, in its sale to Thoma Bravo
- MedeAnalytics in its acquisition of OnFocus Healthcare
- Shareholder of Interactive Data in its sale to the Intercontinental Exchange
- Supreme Oil in its sale to Stratas Foods
- Icopal in its sale to GAP
- Mitsubishi in its $5.39 billion acquisition from Anglo American plc of a 24.5% interest in Anglo American Sur, a Chilean copper mining company
- iParadigms, a portfolio company of Warburg Pincus, in its $752 million sale to Insight Venture Partners and GIC Special Situations
- Milestone Apartments Real Estate Investment Trust, as US special counsel, in connection with its agreement to internalize its asset management business
- Citibank in its sale of EMI Music to Universal Music Group and EMI Music Publishing to a consortium of investors
- Bristol-Myers Squibb in its acquisition of DuPont Pharmaceuticals
- Henry Schein in its investment in, and joint venture with, Maravet
- Johnson & Johnson in its acquisition of Innovasive Devices
- Oracle Corporation in its acquisition of Front Porch Digital
- Hakkasan on its joint venture with MGM Resorts
- Abertis Infraestructuras on the sale of Belfast International airport, Stockholm Skavsta airport, its Orlando airport terminal concession and its airport management business in the US
- Platinum Equity on the acquisition of outdoor media assets from CBS Corporation
- Riverside Partners on the acquisition of Bohemia Interactive Solutions
- Quadriga Capital on the acquisition of Kinetic Systems
- The special committee of Six Flags Entertainment in connection with the company's bankruptcy and assessment of competing plans of reorganization
- iCrossing in the company's sale to the Hearst Corporation
- Openwave in the sale of its mobile messaging and mediation businesses to Marlin Equity Partners
- Lindsay Goldberg in its acquisition of First American Payment Systems
- Ecolochem in its ultra clean water joint venture with Nalco and Ecolochem's sale to Ionics
- The John Frieda Companies in their sale to Kao Corporation
- Conoco in its merger with Phillips Petroleum
- EchoStar in its spin-off from Dish Network
- Global Signal in its merger with Crown Castle
- Jones Apparel in its hostile acquisition of Maxwell Shoe
- Media General in the sale of a number of television markets
- Nestle in its merger with Ralston Purina
- Financial Institutions in connection with numerous transactions, including, most recently, the sale of Silence Therapeutics to Merck KGaA; the sale of Soleno Therapeutics to Neurocrine; John Wiley’s acquisition of Emerald Publishing; the merger of ConocoPhillips and Marathon Oil; Envestnet’s sale to Bain Capital and Royalty Pharma’s acquisition of its manager
Rob serves on several advisory boards and professional committees. He has been a member of the Business Law Partner Advisory Board of Thomson Reuters Accelus, the National Advisory Committee of the Colonial Williamsburg Foundation, the New York Bar Association’s Committee on Mergers & Acquisitions and Corporate Control Contests, Law360’s Life Sciences Editorial Advisory Board and the New York Bar Association’s Corporation Law Committee. Rob sits on the board of LikeMinds Foundation, a not-for-profit that supports Alzheimer’s and Parkinson’s research, and on the board of TheChurch, a non-profit art center, exhibition space and artist residency.